Additional Transcription Factor Compounds: Small Molecules and Peptides
17 results for "Additional Transcription Factor Compounds Small Molecules and Peptides" in Products
17 results for "Additional Transcription Factor Compounds Small Molecules and Peptides" in Products
Additional Transcription Factor Compounds: Small Molecules and Peptides
YAP inhibitor
| Chemical Name: | (4R,4aS)-18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-24H,26H-benzo[b]porphine-9,13-dipropanoic acid monomethyl ester |
| Purity: | ≥95% |
Potent and selective CREB inhibitor
| Chemical Name: | 3-(3-Aminopropoxy)-N-[2-[[3-[[(4-chloro-2-hydroxyphenyl)amino]carbonyl]-2-naphthalenyl]oxy]ethyl]-2-naphthalenecarboxamide hydrochloride |
| Purity: | ≥98% (HPLC) |
Core binding factor inhibitor; attenuates hematopoiesis
| Chemical Name: | 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one |
| Purity: | ≥98% |
Selective inhibitor of ATF6α; sensitizes cells to ER stress
| Chemical Name: | N-[1-[[2,4-bis(Trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)-3-isoxazolecarboxamide |
| Purity: | ≥98% |
TRIM24 Degrader (PROTAC®)
| Chemical Name: | (2S,4R)-1-((S)-15-(tert-Butyl)-1-(3-(N-(1,3-dimethyl-2-oxo-6-(3-propoxyphenoxy)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)sulfamoyl)phenyl)-1,13-dioxo-5,8,11-trioxa-2,14-diazahexadecan-16-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| Purity: | ≥98% (HPLC) |
Selective Smad3 inhibitor; inhibits TGF-βR1 signaling
| Chemical Name: | 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline hydrochloride |
| Purity: | ≥97% (HPLC) |
Potent and selective Foxo1 inhibitor; orally bioavailable
| Chemical Name: | 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| Purity: | ≥98% |
Potent and reversible inhibitor of TEAD mediated Hippo/Yap signalling
| Chemical Name: | 4-[3-(2-Cyclohexylethoxy)benzoyl]-N-phenyl-1-piperazinecarboxamide |
| Purity: | ≥98% (HPLC) |
Hepatocyte nuclear factor 4α (HNF4α) antagonist
| Chemical Name: | 2-Methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole |
| Purity: | ≥98% (HPLC) |
GLI antagonist; inhibits Hedgehog (Hh) signaling
| Chemical Name: | 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine |
| Purity: | ≥98% (HPLC) |
Cryptochrome protein stabilizer; lengthens circadian period
| Chemical Name: | N-[3-(9H-Carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)methanesulfonamide |
| Purity: | ≥98% |
HSF1 inhibitor
| Chemical Name: | N2-1H-Indazol-5-yl-N6-methyl-3-nitro-2,6-pyridinediamine |
| Purity: | ≥99% (HPLC) |
High affinity Nur77 agonist
| Chemical Name: | Ethyl 3,5-dihydroxy-2-(1-oxooctyl)-benzeneacetate |
| Purity: | ≥98% (HPLC) |
Steroid receptor coactivator 3 (SRC-3) inhibitor
| Chemical Name: | 1-(2-Pyridinyl)ethanone 2-(1-methyl-1H-benzimidazol-2-yl)hydrazone hydrochloride |
| Purity: | ≥98% (HPLC) |
High affinity Myc inhibitor
| Chemical Name: | 4-[2-(2-Furanyl)-6-(4-nitrophenyl)-4-pyridinyl]benzamide |
| Purity: | ≥98% |
Inhibits c-Myc-Max dimerization
| Chemical Name: | 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone |
| Purity: | ≥99% |
